Reduction in venous thromboembolism, arterial thromboembolism, and deaths seen in high-risk patients in non-ICU, but not ICU, settings
60 Percent of Americans Will Delay or Skip Flu Shot This Year: Survey
FRIDAY, Oct. 15, 2021 (HealthDay News) — Experts are warning that the upcoming flu season could be severe as social distancing measures are relaxed across the United States, but a …
High Mortality for Psych Disorders Worse During the Pandemic
COVID-19 standardized mortality rates were elevated across nine psychiatric conditions including learning disabilities, eating disorders
Incidence Rates of SARS-CoV-2 Similar for Children, Adults
More infections asymptomatic among children, with 52 percent asymptomatic among those aged 0 to 4 years versus 12 percent in adults
Herpes Simplex Virus and Neurodegenerative Diseases Linkage Identified
A new study by researchers at the University of Illinois Chicago (UIC) suggests that when the protein optineurin (OPTN) is present in cells it restricts the spread of herpes simplex virus type 1 (HSV-1).
This study shows that OPTN selectively targets HSV-1 tegument protein, VP16, and the fusion glycoprotein, gB, to degradation by autophagy.
OPTN deficiency unveils severe consequences for recruitment of adaptive immunity and suppression of neuronal necroptosis.
Furthermore, Ocular HSV-1 infection is lethal without OPTN and is rescued using a necroptosis inhibitor.
Convalescent Plasma Unlikely to Improve Outcomes in Severe COVID-19
Likelihood of improvement in organ support-free days low in critically ill adults with COVID-19 receiving convalescent plasma
Obesity May Up Length of Stay, Mortality for COVID-19 Patients in ICU
Twofold higher risk for composite outcome of death or length of stay ≥14 days seen in obese COVID-19 patients admitted to the ICU
Poor Oral Health Tied to Greater Severity of COVID-19
Subgroup analysis suggests that poor oral health may increase severity of COVID-19 in patients with cardiovascular diseases
Predictors of Smell Recovery ID’d in COVID-19 Patients
Age less than 40 years, nasal congestion at the time of COVID-19 infection positively associated with recovery of smell
FDA Panel Supports Moderna Booster Shot for Older Adults, People at High Risk
Panelists recommended half-dose booster shot six months after the second shot